SHL Telemedicine PE Ratio 2022-2024 | SHLT

Current and historical p/e ratio for SHL Telemedicine (SHLT) from 2022 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SHL Telemedicine PE ratio as of November 22, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

SHL Telemedicine PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-21 2.70 inf
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.040B $0.057B
SHL Telemedicine Ltd is engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Its solutions for healthcare professionals include: CHF monitoring service which supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease and Readmission Solutions for reducing heart-related readmissions. SHL Telemedicine Ltd is based in Israel.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Hims & Hers Health (HIMS) United States $5.276B 134.17
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
Clover Health Investments (CLOV) United States $1.684B 0.00
10x Genomics (TXG) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.484B 0.00
Phreesia (PHR) United States $1.098B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00